Ascletis Pharma (ASCLF) Short Interest Ratio & Short Volume → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free ASCLF Stock Alerts $0.20 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Ascletis Pharma Short Interest DataCurrent Short Volume100 sharesPrevious Short Volume100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$20.23Short Interest Ratio / Days to Cover0.0Last Record DateMarch 31, 2024Today's Trading Volume0 sharesAverage Trading Volume4,243 sharesToday's Volume Vs. Average0% Short Selling Ascletis Pharma ? Sign up to receive the latest short interest report for Ascletis Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatASCLF Short Interest Over TimeASCLF Days to Cover Over TimeASCLF Percentage of Float Shorted Over Time Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. Ascletis Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024100 shares $20.23 No ChangeN/A0 $0.20 3/15/2024100 shares $20.23 No ChangeN/A0 $0.20 2/29/2024100 shares $20.23 No ChangeN/A0.5 $0.20 2/15/2024100 shares $24.90 -90.0%N/A0.5 $0.25 1/15/202453,800 shares $11,298.00 -92.4%N/A18.6 $0.21 12/31/2023706,000 shares $118,749.20 -2.2%N/A557.2 $0.17 Get the Latest News and Ratings for ASCLF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ascletis Pharma and its competitors with MarketBeat's FREE daily newsletter. 12/15/2023722,000 shares $146,421.60 -5.3%N/A0 $0.20 11/30/2023762,000 shares $154,533.60 -20.3%N/A1524 $0.20 11/15/2023956,000 shares $231,925.60 -10.5%N/A239 $0.24 10/31/20231,068,000 shares $222,998.40 No ChangeN/A0 $0.21 10/15/20231,068,000 shares $222,998.40 No ChangeN/A5340 $0.21 9/30/20231,068,000 shares $254,077.20 No ChangeN/A0 $0.24 9/15/20231,068,000 shares $254,077.20 No ChangeN/A0 $0.24 8/31/20231,068,000 shares $254,077.20 No ChangeN/A32363.6 $0.24 8/15/20231,068,000 shares $207,085.20 No ChangeN/A0 $0.19 7/31/20231,068,000 shares $207,085.20 +5.4%N/A0 $0.19 7/15/20231,013,000 shares $196,420.70 +24.3%N/A0 $0.19 6/30/2023815,000 shares $158,028.50 +8.2%N/A0 $0.19 6/15/2023753,000 shares $146,006.70 -7.2%N/A313.8 $0.19 5/31/2023811,800 shares $279,665.10 +9.2%N/A4059 $0.34 5/15/2023743,300 shares $280,075.44 +5.4%N/A177 $0.38 4/30/2023705,000 shares $266,419.50 No ChangeN/A7050 $0.38 4/15/2023705,000 shares $283,057.50 -9.2%N/A3525 $0.40 3/31/2023776,000 shares $239,163.20 +3.7%N/A3880 $0.31 3/15/2023748,000 shares $463,012.00 -2.6%N/A0 $0.62 2/28/2023768,000 shares $475,392.00 +15.1%N/A0 $0.62 2/15/2023667,000 shares $0.00 +7.8%N/A6670 $0.00 1/31/2023619,000 shares $383,161.00 +27.1%N/A3095 $0.62 1/15/2023487,000 shares $292,200.00 +13.8%N/A4870 $0.60 12/30/2022428,000 shares $235,400.00 +259.7%N/A0 $0.55 12/15/2022119,000 shares $65,450.00 No ChangeN/A0 $0.55 11/30/2022119,000 shares $65,450.00 +13.3%N/A0 $0.55 11/15/2022105,000 shares $57,750.00 No ChangeN/A0 $0.55 9/15/20221,000 shares $550.00 No ChangeN/A0 $0.55 5/31/2022134,000 shares $53,600.00 -39.4%N/A148.9 $0.40 5/15/2022221,000 shares $118,654.90 -22.7%N/A0 $0.54 4/30/2022286,000 shares $153,553.40 +23.8%N/A1430 $0.54 4/15/2022231,000 shares $156,987.60 -16.0%N/A577.5 $0.68 3/31/2022275,000 shares $174,240.00 +16.0%N/A51.9 $0.63 3/15/2022237,000 shares $106,721.10 +39.4%N/A1185 $0.45Move Your Money Before May 22 (Ad)The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. ASCLF Short Interest - Frequently Asked Questions What is Ascletis Pharma's current short interest? Short interest is the volume of Ascletis Pharma shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 100 shares of ASCLF short. Learn More on Ascletis Pharma's current short interest. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Ascletis Pharma stock? Short selling ASCLF is an investing strategy that aims to generate trading profit from Ascletis Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ascletis Pharma? A short squeeze for Ascletis Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ASCLF, which in turn drives the price of the stock up even further. How often is Ascletis Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ASCLF, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: 180 Life Sciences Short Interest Data 3SBio Short Interest Data Abcam Short Interest Data Algernon Pharmaceuticals Short Interest Data Alpha Tau Medical Short Interest Data Apollomics Short Interest Data Artelo Biosciences Short Interest Data Ascentage Pharma Group International Short Interest Data Avacta Group Short Interest Data Awakn Life Sciences Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ASCLF) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace